0001354457-23-000871.txt : 20231120
0001354457-23-000871.hdr.sgml : 20231120
20231120084757
ACCESSION NUMBER: 0001354457-23-000871
CONFORMED SUBMISSION TYPE: 25-NSE
CONFIRMING COPY:
PUBLIC DOCUMENT COUNT: 2
FILED AS OF DATE: 20231120
DATE AS OF CHANGE: 20231120
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOCEPT INC
CENTRAL INDEX KEY: 0001044378
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 800943522
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36284
BUSINESS ADDRESS:
STREET 1: 9955 MESA RIM ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-320-8200
MAIL ADDRESS:
STREET 1: 9955 MESA RIM ROAD
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: Nasdaq Stock Market LLC
CENTRAL INDEX KEY: 0001354457
IRS NUMBER: 521165937
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 25-NSE
BUSINESS ADDRESS:
STREET 1: One Liberty Plaza
CITY: New York
STATE: NY
ZIP: 10006
BUSINESS PHONE: 301-978-4144
MAIL ADDRESS:
STREET 1: Office of General Counsel
STREET 2: 805 King Farm Blvd.
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
FORMER COMPANY:
FORMER CONFORMED NAME: The Nasdaq Stock Market LLC
DATE OF NAME CHANGE: 20060224
25-NSE
1
primary_doc.xml
X0203
0001354457
Nasdaq Stock Market LLC
0001044378
BIOCEPT INC
001-36284
5810 Nancy Ridge Drive
San Diego
CA
CALIFORNIA
92121
858 320 8237
Common Stock
17 CFR 240.12d2-2(b)
Aravind Menon
Hearings Advisor
2023-11-20
EX-99.25
2
biocdelistreason.txt
Delisting Determination, The Nasdaq Stock Market, LLC, November 20, 2023,
Biocept, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of Biocept, Inc., effective at the opening
of the trading session on November 30, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rules 5101, 5110(b), and IM-5101-1.
The Company was notified of the Staff determination on October 16, 2023.
The Company did not appeal the Staff determination to the Hearings Panel.
The Company securities were suspended on October 25, 2023. The Staff
determination to delist the Company securities became final on
October 25, 2023.